Beloo Mirakhur - 13 Sep 2021 Form 4 Insider Report for Celularity Inc (CELU)

Role: EVP, Clinical Development
Signature: /s/ Keary Dunn, Attorney-in-Fact
Issuer symbol: CELU
Transactions as of: 13 Sep 2021
Net transactions value: $0
Form type: 4
Filing time: 15 Sep 2021, 18:50:54 UTC
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CELU	Stock Option (Right to Buy)	Award	$0	+125,000		$0.000000	125,000	13 Sep 2021	Class A Common Stock	125,000	$6.87	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option shall vest and become exercisable over a period of four years from the Vesting Start Date, September 13, 2021, with 25% vesting on the one year anniversary of the Vesting Start Date, and 1/48 of the total number of shares each month thereafter over the following three years, such that the options will be 100% vested on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continuous service with the Issuer on each such date.

Content

This option shall vest and become exercisable over a period of four years from the Vesting Start Date, September 13, 2021, with 25% vesting on the one year anniversary of the Vesting Start Date, and 1/48 of the total number of shares each month thereafter over the following three years, such that the options will be 100% vested on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continuous service with the Issuer on each such date.